Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ambulance vital signs may hold clues to brain bleeding outcomes

NCT ID NCT07739030

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study looks back at medical records of people with severe spontaneous brain bleeding (intracerebral hemorrhage) to see if vital signs measured before arriving at the hospital—like blood pressure and heart rate—are linked to recovery and survival six months later. The goal is to understand which early physiological factors might influence outcomes in this serious condition. By identifying these factors, the study could help improve emergency care and guide decisions about treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If certain prehospital vital signs are linked to outcomes, this could help emergency teams identify high-risk patients earlier and guide more personalized treatment.
What could go wrong
This is a retrospective observational study, so it can only show associations, not cause and effect. The findings may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

678 people

The number who actually took part.

Started

Nov 2016

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study included all patients admitted to the neurointensive care unit at Copenhagen University Hospital Rigshospitalet, ≥18 years with primary spontaneous ICH from November 1, 2016, to October 1, 2025. Patients initially admitted to peripheral hospitals, including non-stroke units, prior to transfer were also eligible for inclusion.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Primary spontaneous ICH confirmed by CT imaging. * Admission to the neurointensive care unit at Rigshospitalet within the study period. * Available prehospital journal linked to the initial hospital admission. Exclusion Criteria: * Age below 18 * ICH secondary to trauma, vascular malformation, tumour, haemorrhagic transformation of ischaemic stroke, aneurysms, or central venous sinus thrombosis. * Initial admission without confirmed ICH. * Admissions from hospitals outside the Capital Region of Denmark or Region Zealand. * Pure intraventricular hemorrhage without parenchymal involvement as determined by a radiologist. * Intrahospital ICH. * Iatrogenic ICH

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ich - intracerebral hemorrhage are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rigshospitalet

    Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.